Coya director granted 10,000 stock options
Coya Therapeutics, Inc. director Mark H. Pavao received a grant of stock options covering 10,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Coya Therapeutics, Inc. director Mark H. Pavao received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of $4.53 per share, expire on April 9, 2036, and will vest 100% on the first anniversary of the grant date, subject to continuous service.
Insider Trade Summary
Grant/Award: 10,000 shares
Grant/Award
1 txn
Insider
Pavao Mark H
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 10,000 contracts (Direct)
Holdings Before and After:
Stock Option (right to buy), 0 to 10,000 contracts (Direct)
Footnotes (1)
- F1. Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.
Key Figures
Option grant size: 10,000 shares
Exercise price: $4.53 per share
Expiration date: April 9, 2036
+2 more
5 metrics
Option grant size
10,000 shares
Stock Option (right to buy) granted to director
Exercise price
$4.53 per share
Conversion or exercise price of stock option
Expiration date
April 9, 2036
Option term end date
Underlying shares
10,000 shares
Common stock underlying the option
Post-grant derivative holdings
10,000 options
Total stock options following transaction
Key Terms
Stock Option (right to buy), exercise price, continuous service, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "4.5300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
continuous service financial
"Subject to continuous service, 100% of the option will vest"
vesting financial
"100% of the option will vest on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Coya Therapeutics (COYA) director Mark H. Pavao report in this Form 4?
Director Mark H. Pavao reported receiving a grant of stock options for 10,000 shares of Coya Therapeutics common stock. These options were granted at an exercise price of $4.53 per share and are held as a direct ownership position following the transaction.
What is the exercise price of the Coya Therapeutics (COYA) options granted to Mark H. Pavao?
The options granted to Mark H. Pavao have an exercise price of $4.53 per share. This means he can purchase Coya Therapeutics common stock at $4.53 per share once the options vest and are exercisable, subject to the award’s terms.
When do Mark H. Pavao’s Coya Therapeutics (COYA) stock options vest?
The stock options will vest 100% on the first anniversary of the grant date. Vesting is conditioned on his continuous service through that date, meaning the entire 10,000-share option becomes exercisable after one year if service continues.
What is the expiration date of the Coya Therapeutics (COYA) stock options granted?
The granted stock options expire on April 9, 2036. After this expiration date, any unexercised portion of the 10,000-share option will no longer be exercisable, according to the terms disclosed in the Form 4 filing.
Is Mark H. Pavao’s ownership in Coya Therapeutics (COYA) direct or indirect after this grant?
The Form 4 indicates that Mark H. Pavao’s ownership of the stock options is direct. The ownership code is listed as “D” for direct, and there is no referenced intermediary entity or indirect ownership structure in the disclosed transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
